🕵️ CNS Pharmaceuticals, Inc. ($CNSP)
SEC insider & ownership activity, last 12 months · CIK 1729427 · every row links its SEC filing
Over the last 12 months insiders bought $34K with no open-market selling against it. Faith L. Charles bought $34K in discretionary trades (May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $34K (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Faith L. Charles | 1 | $34K | 0 | – | May 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Stonepine Capital, L.P. | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Stonepine GP, LLC | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Jon M. Plexico | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Ikarian Capital, LLC | 5.7% | 13G | Apr 17, 2026 | filing ↗ | |
| Neil Shahrestani | 5.7% | 13G | Apr 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 2, 2026 | filing ↗ |
| Material agreement (1.01) | May 4, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 4, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 16, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 17, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Nov 17, 2025 | filing ↗ |
| Shareholder vote (5.07) | Nov 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 17, 2025 | filing ↗ |